| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | - | - | 41.774 | 71.084 | 53.147 | 39.254 | 41.131 |
| Total Income - EUR | - | - | - | - | - | 41.774 | 71.084 | 53.147 | 39.254 | 41.131 |
| Total Expenses - EUR | - | - | - | - | - | 227 | 398 | 2.472 | 7.975 | 13.969 |
| Gross Profit/Loss - EUR | - | - | - | - | - | 41.547 | 70.686 | 50.675 | 31.280 | 27.162 |
| Net Profit/Loss - EUR | - | - | - | - | - | 40.321 | 68.553 | 49.080 | 26.275 | 22.816 |
| Employees | - | - | - | - | - | 0 | 0 | 0 | 0 | 0 |
Check the financial reports for the company - Ati Dr. Gherghina Viorel S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | - | - | 0 | 0 | 0 | 0 | 0 |
| Current Assets | - | - | - | - | - | 40.888 | 108.363 | 91.637 | 27.870 | 25.269 |
| Inventories | - | - | - | - | - | 0 | 0 | 0 | 0 | 0 |
| Receivables | - | - | - | - | - | 83 | 81 | 2.606 | 18.945 | 7.320 |
| Cash | - | - | - | - | - | 40.806 | 108.282 | 89.031 | 8.925 | 17.948 |
| Shareholders Funds | - | - | - | - | - | 40.363 | 108.021 | 49.121 | 26.323 | 22.865 |
| Social Capital | - | - | - | - | - | 41 | 40 | 41 | 40 | 40 |
| Debts | - | - | - | - | - | 526 | 342 | 42.516 | 1.547 | 2.404 |
| Income in Advance | - | - | - | - | - | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Ati Dr. Gherghina Viorel S.r.l.